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Abstract
Background: Proteases play a central role in cellular homeostasis and are responsible for the spatio- temporal regulation of
function. Many putative proteases have been recently identified through genomic approaches, leading to a surge in global
profiling attempts to characterize their function. Through such efforts and others it has become evident that many
proteases play non-traditional roles. Accordingly, the number and the variety of the substrate repertoire of proteases are
expected to be much larger than previously assumed. In line with such global profiling attempts, we present here a method
for the prediction of natural substrates of endo proteases (human proteases used as an example) by employing short
peptide sequences as specificity determinants.
Methodology/Principal Findings: Our method incorporates specificity determinants unique to individual enzymes and
physiologically relevant dual filters namely, solvent accessible surface area-a parameter dependent on protein three-
dimensional structure and subcellular localization. By incorporating such hitherto unused principles in prediction methods,
a novel ligand docking strategy to mimic substrate binding at the active site of the enzyme, and GO functions, we identify
and perform subjective validation on putative substrates of matriptase and highlight new functions of the enzyme. Using
relative solvent accessibility to rank order we show how new protease regulatory networks and enzyme cascades can be
created.
Conclusion: We believe that our physiologically relevant computational approach would be a very useful complementary
method in the current day attempts to profile proteases (endo proteases in particular) and their substrates. In addition, by
using functional annotations, we have demonstrated how normal and unknown functions of a protease can be envisaged.
We have developed a network which can be integrated to create a proteolytic world. This network can in turn be extended
to integrate other regulatory networks to build a system wide knowledge of the proteome.
Citation: Venkatraman P, Balakrishnan S, Rao S, Hooda Y, Pol S (2009) A Sequence and Structure Based Method to Predict Putative Substrates, Functions and
Regulatory Networks of Endo Proteases. PLoS ONE 4(5): e5700. doi:10.1371/journal.pone.0005700
Editor: Andreas Hofmann, Griffith University, Australia
Received February 7, 2009; Accepted April 28, 2009; Published May 27, 2009
Copyright:  2009 Venkatraman et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The authors have no support or funding to report.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: vprasanna@actrec.gov.in
Introduction
Proteases can activate or truncate functions of proteins, unfold a
cascade of events, trigger development or differentiation and cause
cell death [1,2]. Regulation of proteolysis is therefore vital to
cellular homeostasis. Due to such intricate involvement of
proteases in a variety of cellular functions, it is not surprising that
aberrant changes in regulation of their function is associated with
many malignancies [2]. While a large number of proteases have
been identified over the years, only a few corresponding natural
substrates have been recognized. Therefore, the general role of
these proteases under normal conditions is not as obvious as their
role for example, in tumor invasion [3–5]. Several different
methods are presently employed to bridge the existing gap
between information pertaining to natural substrates and the
normal physiological function of proteases [6–13]. While one
would expect computational approaches to be an integral part of
such investigation, very few in silico methods are currently available
for the prediction of natural substrates of proteases. CaSPredictor
for the prediction of caspase substrates [14], GraBCas for
Granzyme B and caspase substrates [15] are notable among
them. These tools are classifiers designed for high accuracy and
are based on known natural substrates which act as training sets.
Such techniques are therefore restricted to few well studied
enzymes such as caspases, trypsin and granzymes and cannot be
extended to other proteases. CutDB is a curated database that
currently documents proteases from all organisms, along with their
experimentally identified and predicted substrates [16]. Newer
approaches and programs have been designed catering to protease
families. Prediction of Protease Specificity, PoPS [17] is a server
which tries to predict natural substrates by finding matches for a
potential enzyme active site. It provides an environment to the
user to model substrate specificity using available information.
Since the output is user dependent, results are prone to be
erroneous.
As a result we felt that there is a definite requirement to find
prediction methods for large scale global profiling of natural
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of minimal sequence motifs for this purpose. Minimal motif of
three amino acids is apparently sufficient to confer functional
specificity in proteins [18]. In our method we have used two basic
principles inherent to proteolysis namely, (a) sequence specific
information [19] or the qualitative criterion, and (b) a three
dimensional structure (3D) related quantitative criterion, called
relative solvent accessibility. Using this method we report here in
silico identification of substrates of serine proteases from the
Protein Data Bank (PDB) [20] and a database of protein disorder,
DisProt [21]. Using relative solvent accessibility and subcellular
distribution as filters we perform subjective validation of potential
substrates of matriptase and assign new functions to this enzyme.
Furthermore, using relative solvent accessibility as a criterion, we
project a novel method to build proteolytic cascades and
regulatory networks. In addition we have projected the use of
sequence specific information to identify putative substrates of
majority of human endo proteases from the entire human
proteome. It is anticipated that the position specific information
on substrate specificity, structural (of the enzyme and substrate)
and localization information will increase the accuracy of the
prediction methods and eliminate the false positive ones from the
ensemble.
Results
To identify a minimal specificity motif, which can be used to
provide as accurate and robust predictive method as possible, we
considered several features of enzyme catalysis. They are 1)
specificity determinants unique to each protease type, 2)
discriminative power of different enzymes within the catalytic
type, 3) accessibility of the cleavage site and 4) localization. While
the primary site specificity has been extensively used in some of the
other predictive methods, no one has arrived at a general formula
capable of addressing proteases of an entire catalytic type as a
whole. No one explicitly considers the tertiary structure informa-
tion or protein localization, both of which are of considerable
importance in vivo.
I. Guideline 1
a) Cleavability based on sequence specificity–a
qualitative criterion. Cleavage sites on proteases are short
and span a contiguous stretch of residues of the type P4P3P2P1-
P19P29P39P49 with the scissile bond between the P1-P19 residues.
Proteases can also cleave short peptides of two or more residues.
MEROPS, the peptidase database [22], is a manually curated
information resource for peptidases, which enlist all such
experimentally observed cleavage sequences. We call such short
peptide sequences as the ‘artificial peptide substrates’. In many
instances such short peptide sequences have been used either in
the design of inhibitors or in position scanning approaches to
optimize the sequence specificity [9,23,24]. Some investigators
have made best use of such information by identifying disallowed
amino acids to discriminate between proteases of similar specificity
[25]. Therefore, these short sequences harbor valuable
information. Keeping these in mind we simply asked whether
such minimal sequences can be used to link MEROPS, with PDB,
DISPROT and the human proteome databases. We call this
approach: ‘Prediction of Natural Substrates from Artificial
Substrate of Proteases’ (PNSAS).
In order to retrieve sequences that can be used for the
prediction, we cataloged the number and type of short peptide
substrates in MEROPS (Table 1) wherein peptides of varying
length (one-where a single amino acid is linked to a fluorophore to
those which are eight amino acids long) are reported. Predictions
based on very short sequence will tend to be more non-specific and
those with large number of residues more restrictive. To obtain a
balance between specificity and versatility, we chose to study
tripeptide sequences. As seen below, they represent an optimum
number for large scale positive identification. Moreover, our
preliminary screening against the PDB database wherein we derive
the structural information vital to our method indicated that a
reasonable number of hits amenable for analysis will be obtained
using tripeptides. Most often in such short peptide substrates, the
P19 position is designed to have a fluorophore (of varying sizes) to
enable activity measurements. However proteases, for example,
caspases show clear discrimination for amino acids at P19 position
incorporation of which should help in the prediction methods [26].
In addition to the artificial peptide substrates, MEROPS also
documents experimentally identified cleavage sequences from
natural substrates. These are recorded as octapeptide sequences in
MEROPS with the 4
th and 5
th residue corresponding to the P1
and P19 positions. These longer octapeptide sequences would be
more specific, but also restrictive. By virtue of being more specific
these can be used against a large database like the entire human
proteome. However, the limitations of such relatively long
sequences are apparent when additional filters need to be
incorporated based on the 3D structure of the protein. PDB is a
much smaller data base and as will be seen below provides limited
output with the octamers.
From the MEROPS data base, we downloaded all the uniprot
sequences of those proteins reported to be cleaved by the four
major types of proteases namely, metallo, cysteine, aspartate and
serine proteases. We extracted all the octapeptide cleavage
sequences from these natural substrates and made a query set
which we call the NQSS (Naturally derived Query Sequence Set;
Table S1). We developed a method to extract pattern matches
within a dataset when a query is placed (which in this instance is a
contiguous stretch of eight amino acids). To verify applicability of
the method, we concentrated on serine proteases and chose two
proteases for which a significant number of substrates have been
identified: furin and thrombin. We split the substrates into a
training and test set. The octapeptide cleavage sequences (16/31
for furin and 55/109 for thrombin), not surprisingly, fetched 100%
hits from the training set. We then used 964 uniprot sequences that
correspond to all the natural serine protease substrates reported in
MEROPS. From this data set 48 and 68% of substrates were
correctly identified by the furin and thrombin training sets,
respectively (Table 2). More than one hit (perfect match) i.e.,
alternative cleavage sites within the same protein are not counted
here but the results are tabulated separately (Table S2). We also
derived shorter sequence motifs of four and three amino acids long
(P3P2P1P19 and P3P2P1) and repeated the exercise to see if we
can increase the coverage of the known substrates. As clearly seen
from Table 2, tripeptide query sequence set (QSS) fetched 85 and
98% of the already identified substrates of furin and thrombin
respectively, while the tetrapeptide QSS fetched 56 and 79% of
the substrates respectively (Table 2). Also to be noted is the fact
that in going from the octapeptide to the tripeptide QSS, the
number of hits obtained increases almost exponentially. A
tripeptide motif therefore has the best representation of the
cleavage sequences, offers the advantage of extensive coverage and
greater flexibility in identifying new substrates. The caveat is that
large number of false positive identifications is inevitable.
Our simple algorithm looks only for a perfect match for an
experimentally derived peptide sequence and does not allow any
flexibility/mismatches. We deliberately refrain from introducing
any variable in the sequence, as our aim is to find exact matches
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specific query set, we used the octapeptide cleavage sequences of
serine, metallo, cysteine and aspartic proteases and identified
matches from the entire human proteome (Table S3). Identified
proteins are regarded as the most highly likely substrates of these
proteases provided they pass through the biologically relevant
filters described below.
b) Differential specificity between enzymes of the same
family. While the active sites of enzymes of an entire protease
type show common preference for residues at the scissile bond (P1-
P19), with a few exceptions, individual enzymes from within the
same catalytic type may have unique preferences at other positions
[9]. Short synthetic peptides (called artificial here) are often
designed to measure activity or optimize binding. We assembled
all the short tripeptide sequences listed in MEROPS (although not
every one of them would be an optimized sequence) for the
enzymes of the serine protease type and short listed those that
confirmed to the following kind: P3P2P1. Residue at P19 was
ignored. Using these peptides, a library was created and referred
to as ‘Artificial Query Sequence Set’ (Table S1). This is a
representative set and the guiding principles have been derived
from experimental determination. Unique and additional
specificities have been reported for furin (RxR/KR) [27] and b-
tryptase (PRNR) [28]. Therefore, their query sequences were
designed accordingly to include the tetrapeptides. In the case of
furin, we could not find in MEROPS, peptide substrates that
confirmed to the P3P2P1 type. It is to be emphasized that
accuracy of our method is strongly dependent on experimental
determination of position specific information and will improve
when rigorously optimized sequences are available for a protease,
including information about those that are disallowed in some
positions between closely related proteases [25]. A right
combination of amino acids at the appropriate position which
takes into account the specificity dictated by an enzyme active site
constitutes a qualitative criteria, called ‘cleavability’.
To obtain an idea about the representation of amino acid type
within the artificial peptide substrates of serine proteases, we
tabulated the observed cleavage sequences and compared the
amino acids present at the scissile bond (data not shown). Majority
of the proteases of the serine catalytic type harbor Arg/Lys and so
do the artificial short peptide substrates. In granzyme B, a
preference for Asp, an oppositely charged residue was observed
which was also reflected in the artificial peptide query set. As
mentioned before, the P19 position seems to be flexible and it is
generally utilized to add a fluorophore which varies in size and
type. Although Ser seems to dominate the P19 position in most of
the natural cleavage sequences, with 35/63 proteases having at
least one cleavage sequence with P19 serine, other types of amino
acids were also observed reflecting flexibility at this position (data
not shown). In some instances, protease specific information was
also evident as in the case of thrombin where P2 is predominantly
occupied by a proline residue. Representation of amino acids
present in the natural substrates, increases the level of confidence
in a predictive approach using short peptides of the kind described
Table 1. Summary of the number and type of peptide substrates in MEROPS database.
Catalytic Type Length Of the Peptide Substrates Total number of substrates
12 3 45678
Serine 55 120 102 43 15 37 38 600 1010
Aspartate 04 4 3721 7 2 7 2 3 0 9
Cysteine 21 41 22 25 11 9 17 633 779
Threonine 59 9 60003 3 2
Metallo 6 120 42 19 74 38 56 633 988
Peptides one to seven amino acids long were derived from short peptide substrates (synthetic/artificial). Peptide of length ‘one’ indicates a single amino acid followed
by a fluorophore and the fluorophore itself is not counted. Peptides with eight amino acid residues were derived from natural protein substrates.
doi:10.1371/journal.pone.0005700.t001
Table 2. Identification of reported substrates of furin and thrombin using Query Sequence Set.
Peptide Length Furin Thrombin
Octa peptide Tetra peptide Tri peptide Octa peptide Tetra peptide Tri peptide
Total Known natural substrates 27 27 27 98 98 98
Training Set 16 16 16 55 55 55
Number of proteins identified from entire 964 uniprot
sequences of natural substrates of human serine
proteases*
19 127 714 73 348 840
Known substrates-correct identification 13/27 15/27 23/27 67/98 77/98 96/98
Percentage correct identification 48% 55.6% 85% 68% 78.6% 98%
Putative novel substrates identified 6 112 691 6 271 744
Furin and thrombin cleavage sequences from the natural substrates were extracted and a training set of different types, i.e. octa, tetra and tri peptides were created. The
terapeptide sequence indicates P3P2P1P19 and the tripeptide sequence indicates P3P2P1 residues. The ability of these query sequences to retrieve known/reported
substrates was analyzed as described under methods.
*Note that for the sake of clarity the number of proteins and not the number of cleavage sites are reported here.
doi:10.1371/journal.pone.0005700.t002
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S1) was used to query the human proteome database for exact
matches (Table S4). We have also used the tripeptide QSS of
serine proteases (part of the NQSS; for example see tripeptide
query sequence of furin and thrombin in the training set –Table
S1) derived from the naturally identified substrates and scanned
the human proteome for exact matches which would be made
available on our website. Matches for the tetrapeptide query
P3P2P1P19 would be a subset of this data.
II. Guideline 2
Accessibility - a quantitative criterion. For a ‘cleavable’
sequence within the protein (as identified above) to be cut by the
corresponding protease, the cleavage site must either be surface
exposed or present in flexible/disordered region (accessible) in the
context of the folded 3D structure of the protein. To obtain such
structural information, we queried octapeptide cleavage sequence
(NQSS) against human proteins derived from PDB (Table S5).
To ‘quantify’ accessibility, we calculated Solvent Accessible
Surface Area or SASA [29]. To attribute the contribution of
SASA to accessibility, we calculated relative values (rSASA) by
considering the highest SASA value as 1 (Table S5). For
validation we excluded those hits which were not reported in
MEROPS (potential novel substrates). Majority of the cleavage
sites (90.7%) had an rSASA value .0.4. Structures of some of
these proteins are shown in Figure 1. As noted before, NQSS
contains all the octapeptide cleavage sequences for the four major
protease type: metallo, cysteine, serine and aspartate. Our ability
to fetch back the proteins documented in MEROPS from PDB
illustrates the applicability and the reliability of the method. Also,
one would expect this approach to be useful to at least a vast
majority of endo proteases in general and the exceptions are
discussed below.
We also queried the PDB with the short artificial peptide QSS
of serine proteases and classified the PDB hits into those with
rSASA $0.4 (most likely substrates) and those ,0.4 (Table S6).
For comparative purposes, the SASA values of the octapeptide
cleavage sequences within the known natural substrates were
recalculated using only the P3P2P1P19 residues (Table S5). Based
on this calculation, 69% of substrates had rSASA values $0.4 and
87% of the substrates $0.3. One may use the lower ($0.3 instead
of $0.4) cutoff to include more likely substrates. If two different
proteases have a cleavable sequence on the same protein or the
same protease has different cleavable sites on the same protein, the
site with more accessibility ($0.4) would be considered as a more
likely candidate than those with rSASA below 0.4. Many cleavage
sites were present in regions with no distinct electron density which
are considered as disordered regions, or regions with high degree
of flexibility. Since SASA cannot be calculated for such regions, an
arbitrary value of 2 was assigned as a quantitative measure.
However, when such disordered regions were present in the very
beginning or end of the PDB structure they were in general
ignored for the following two reasons: 1. processing at the very
termini may have less biological sense unless it inactivates the
enzyme; 2. the PDB structure may have a partial sequence in
which case the site may not be disordered or accessible in the full
length protein.
Apart from their lack of electron density in crystal structures,
disordered regions have been identified in proteins using other
experimental strategies and are documented in DisProt, a database
of protein disorder [21]. Such regions span short stretches or run
through the entire length of the protein. These regions were
scanned for exact matches (Table S6) using artificial QSS listed in
Table S1. Our analysis of the known natural protein substrates
indicated that cleavage sites are often present in disordered regions
of proteins. Therefore, we believe that proteins containing
sequence matches within the disordered regions are very likely
candidate substrates. Disordered or flexible regions are often
suspected to be proteolytic targets [30] and we provide a platform
to test this by identifying a potential enzyme-substrate pair. Due to
the small size of this database as well as the PDB, matches were
not observed for many enzymes.
III. Identification of putative substrates of matriptase
In order to validate our method we undertook subjective
analysis of the substrates of matriptase, an epithelial membrane
bound serine protease also found in extracellular environment.
Although its normal functions are yet to be clearly elucidated, it is
presumed to be involved in adhesion, growth, proliferation and
differentiation [31]. It is also implicated in a wide variety of
cancers involving the epithelium, particularly in tumor invasion
and angiogenesis [32,33].
Position scanning approaches and the power of phage display
have been used to identify the sequence preference of matriptase
[34]. These studies identified two consensus sequences-one with
the P4-P19 positions occupied by R/KXSRA and the other with
XR/KSRA where X is a non-basic residue. The artificial peptide
substrates in MEROPS [35] belong to the type where P3 is a non-
basic residue and P1 is always an R (except for AFK). Although
Ala has been identified as the preferred P19 residue proposed
cleavage sequences in natural substrates of matriptase contain Val,
Ile, Gly or Ser indicating that P19 may accept a variety of amino
acids [31,32]. The phage library selection indicates that either P3
or P4 could be basic, but not both. However, activation sites of
matriptase on profilaggrin have been mapped to RKRR-G [32]
and that of VEGRF 2 to RRVR-K [31]. This is in variance with
the projections from phage library.
To obtain structural insights about the binding pocket in
matriptase, we have docked a common scaffold EGRS with Arg
(REGRS) and Ala (AEGRS) at the P4 position. Both peptides
fitted well within the binding pocket. The pentapeptide AEGRS
(GlideScore of-9.035 kcal/mole) seems to bind tighter than
REGRS (GlideScore of 26.730 kcal/mole), as can be seen from
its compact positioning in the matriptase cavity (Figure 2). The
guanidinium group of P1 Arg is set deep into the S1 pocket of the
protein and is hydrogen bonded to Ser190 and Gly219. These
interacting residues and the P1 Arg are held in position within the
pocket made of Cys191, Val213, Gly216, Trp215 and Phe99. A
salt bridge between P1 Arg and Asp189 reinforces the enzyme
substrate interaction. Asp184 and Gly193 interact with the
carbonyl carbon of the scissile bond which is covalently bound
to the catalytic serine (Ser 195). Ser at the P19 position is held
within the binding pocket via long range van der Waals and
electrostatic interactions with the His57 side chain and Ile41
backbone carbonyl oxygen. The P3 glutamate side chain
carboxylate is hydrogen bonded to the side chain amide of
Gln192 and P4 Ala is in energetically stable hydrophobic contact
with Ile60 isobutyl side chain. In addition, interactions between
the carboxylate moiety of the P3 Glu side chain of the ligand and
the phenolic side chain of Tyr146 can be potentially mediated by a
water molecule. When P4 is an Arg, additional hydrogen bonding
interactions are made by the P4 side chain guanidinium group
with Ile60 and Cys58 backbone carbonyl oxygen. Nevertheless, a
lower binding affinity is predicted for this sequence, possibly due to
the assessment of energetic penalty for the solvent exposure of the
trimethylene chain formed by C
b,C
c and C
d atoms in the side
chain of the P1 Arg. Additional docking studies showed that the
pocket holding the P19 residue was able to accommodate multiple
Natural Protease Substrates
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with no drastic change in the binding geometry as the glutamine
side chain amide is able to engage the side chain of Gln192 (similar
to P3 Glu). Non-specific peptides like AAADS (GlideScore of
0.23 kcal/mole) demonstrate considerably reduced binding to the
matriptase active site with GlideScore values being nearly 10 kcal/
mole higher than the specific sequence AEGRS.
The above results indicate that proteases can indeed discrim-
inate between short peptide sequences and the active site is in fact
adopted to specifically bind closely related peptides. Therefore,
even if the number of hits using these small sequences is going to
be huge, position optimized sequence information can indeed be
used in silico as a first line of screening to map protease cleavage
sites in a high throughput manner.
Analysis of human proteome results
Due to the results obtained by docking studies and the fact that
even within the small set of natural substrates of matriptase
identified so far, the rules of phage display library are in variance,
we have used, P3P2P1 as QSS to screen for matches with the
human proteome (Table S4). Some of the experimentally
identified natural substrates of matriptase are matriptase itself,
profilaggrin, pro-uPA, MMP3, laminin, collagen type IV,
fibronectin, gelatin, pro HGF, VEGF2 and PAR-2 [31–33,36].
Although activation of many of the above proteins by matriptase
has been demonstrated, the exact in vivo processing is unclear and
most of the substrates are referred to as ‘putative’. The P2 and P3
residues in these proteins (with the exception of matriptase) are
different from those present in QSS. The expected cleavage site of
matriptase harbors QAR, a motif present in our query set, but the
P19 position is occupied by Val. We identified matches with
urokinase plasminogen activator preproprotein, laminin b-3
precursor, filaggrin and collagen from the human proteome
indicating that there are alternative cleavage sites than those
proposed earlier. Some of these protein substrates are homologous
(collagen) or mature forms (filaggrin) of previously identified
substrates. It will be interesting to see which one of these cleavage
sites would be the preferred in vivo and how proteolysis is halted
without cleavage at other sites. Accessibility of the site and/or the
exosite specific preferences [37], tissue specificity, subcellular
localization and topology would play a decisive role in this
instance. To what extent relative rates of cleavages would help in
differential susceptibility remains to be seen.
As mentioned before, the exact physiological role of matriptase
in health and malignancy still remains to be clarified. The protease
however is speculated to be involved in protease activation,
epithelial and keratinocyte differentiation, receptor activation,
growth factor stimulation, cell adhesion and matrix degradation
Figure 1. The three dimensional context of the cleavage sequences in natural substrates. a) Structures of the known protein substrates of
proteases with their octapeptide cleavage sequences are depicted in cyan. Amino acids at the P1 and P19 positions are represented as sticks. Protein
structure is represented as a surface. The rSASA values for the P3P2P1P19 sequence is shown in parenthesis.
doi:10.1371/journal.pone.0005700.g001
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like protein, fibroblast growth factor, many of the G protein
coupled receptors and proteins, spermatogenesis associated
homolog and keratin may be the candidate substrates under such
conditions. Matriptase is associated with epithelial cancer, their
metastasis, invasion and angiogenesis. Cancer-related proteins like
epithelial cell transforming sequence 2 oncogene protein, FAT
tumor suppressor 2 precursor, proto-oncogene tyrosine-protein
kinase FGR, serologically defined colon cancer antigen, and
angiotensin II receptor-associated protein are candidate substrates
of matriptase predicted by our method.
Analysis of PDB results
We used matriptase QSS containing P3P2P1 residues to fetch
matches from the PDB. Besides addressing similar questions as
with the human proteome, structural information in PDB permits
one to ask a more physiologically relevant question, i.e., is the
identified site accessible or not? Proteins with matches to
matriptase query set were rank ordered according to their rSASA
values (Table S7). Out of 772 human proteins that were short-
listed from PDB, we found 269 hits for matriptase query sequences
(35.0%). After imposing rSASA filter (0.4), the number of hits was
reduced to 100 (12.95%). Figure 3 shows structures of some of
these proteins emphasizing the accessibility of the cleavage
sequence.
Not all proteins with accessible sites will be cleaved by a
protease. Therefore yet another filter was created to restrict false
positive hits. The filter was set as co-localization, a prerequisite
that the protease and its potential substrate should be present in
the same subcellular compartment (Table S8). Proteins localized
to the membrane/extracellular region and an rSASA $0.4 were
short-listed. This further reduced the number of likely candidates
to 39 (5%). Matriptase is found either bound to the membrane
with the catalytic site facing the extracellular milieu or is secreted
into the extracellular environment. Those substrates that were
membrane bound were further scrutinized to identify the
topological location of the cleavage site. It turns out that in many
such proteins which were characterized as membrane bound/
extracellular, the actual cleavage site is present in the cytoplasmic
region which is less likely to be cleaved by matriptase. Thus by
following these stringent criteria the number of potential substrates
was reduced to 16 (2%).
During this exercise we found several discrepancies about the
information pertaining to subcellular localization, identification of
the topology of a membrane protein and mapping of the cleavage
sequence. In many instances, the subcellular localization was
unclear. Localization is referred to as membrane, integral
membrane or extracellular under the GO terms in PDB. We
referred to uniprot data to identify the subcellular localization.
Even in uniprot there are varying annotations- sometimes the
localization is inferred by electronic annotation or it is referenced
to ‘traceable to an author’. It is very difficult under such conditions
to unequivocally assign the subcellular loci to the protein and the
topology could be assigned only upon further reference to other
databases or via comparison with the homologous sequences with
relevant information. We illustrate this by two examples. Two of
the Ephrin receptors 2 and 3 were found to have the cleavage
sequence for matriptase. While the Ephrin receptor 3 details are
clearly available in the uniprot to map the cleavage sequence,
those of Ephrin receptor 2 is not. Ephrin receptor 3 has a mutation
within the cleavage sequence in the recombinant protein. It is a
LGR in PDB, while the uniprot natural sequence is LSR. The
sequence lies within the kinase domain and therefore would face
the cytoplasmic side. The cleavage sequence in Ephrin receptor 2
Figure 2. Structure of matriptase docked with a model peptide substrate. A) AEGRS (spheres) was docked to the matriptase structure
(2GV6; light blue) using various components of Mastero (Schro ¨dinger) as described under Text S1. Residues that are 4 A ˚ distance from the ligand are
shown as sticks. Polar interactions of the ligand with active site residues are indicated as dashes (yellow).
doi:10.1371/journal.pone.0005700.g002
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therefore could be a putative substrate. Yet another interesting
example is the Mast/stem cell growth factor receptor (2EC8). We
identified a cleavage sequence AFK in this protein which is
topologically located in the extracellular region. The PDB
structure however did not have the uniprot reference to it. We
independently queried the protein in uniprot and found that the
cleavage site is located in the potential extracellular domain.
Interestingly, mutations in this protein leading to overactive kinase
is associated with gastrointestinal stromal tumors [38]. It would be
interesting to see the role of matriptase, if any, on the proteolytic
processing of this protein, resultant activation of the kinase and its
effect on such tumors.
We also found examples where the cleavage sites confirm to all
stringent criteria but are present within the functional domain of a
protein, for example, those of MMP9 and FGF23. Such cleavages
would inactivate the protein. Inactivation of MMP9 by matriptase
would be contradictory to the known role of matriptase in tumor
invasion [39]. At present the relationship between matriptase
activity and MMP9 inactivation is unclear, although it is possible
that matriptase may inactivate MMP9 under normal conditions to
attenuate a physiological function from stepping out of regulation,
for example, in bone resorption and development [3]. It is possible
that there are differences in proteolytic patterns between normal
and pathological conditions. However, any such reasoning as
mentioned here is highly speculative and needs to be treated with
extreme caution.
Careful analysis of the structure and accessibility of the cleavage
sequence has an immense impact in deciding for or against a
possible cleavage site especially if (a) such an additional site has not
been previously reported or (b) the cleavage of which may lead to
inactivation of the enzyme. Vascular endothelial growth factor
receptor 2, an integral membrane protein involved in angiogenesis
has recently been identified as a potential substrate of matriptase
[31]. Our search picked an alternative cleavage site GRG (rSASA
0.48; Figure 3) in this protein from the PDB. However,
topologically the site was found to be located on the cytoplasmic
side of the membrane and therefore is unlikely to be cleaved by
matriptase. Similarly, in the case of urokinase plasminogen
activator, a secretary protein, we identified a cleavage sequence
EGR with P19 Cys. This cleavage sequence is present within the
kinase domain and cleavage at this site is likely to inactivate the
protein. Careful look at the structure indicates that this Cys residue
is involved in a disulfide linkage. It will be interesting to find if the
presence of such a disulfide bond would prevent cleavage at this
site.
Figure 3. Three dimensional context of the cleavage sequences in putative substrates of matriptase. Structures of the putative
substrates of matriptase with their tetrapeptide cleavage sequences are depicted in the format described in Figure 1.
doi:10.1371/journal.pone.0005700.g003
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we set about deriving functional information about matriptase.
The final 16 potential substrates were grouped based on their GO
function [40]. The results (Figure 4) show that our method has
identified proteins involved in cell adhesion, matrix/membrane
organization, cell proliferation and differentiation as potential
substrates. Matriptase is presumably involved in these functions
[31,32,35]. However, only one or two substrates associated with
such functions have been reported to posses the putative cleavage
sequence for matriptase. We have identified more potential
substrates of matriptase in these functional categories. Further-
more, by grouping several potential substrates, role played by a
protease can be discerned or new functions assigned far more
confidently than when dealing with isolated substrates. By such an
analogy, we have identified regulation of carbohydrate metabolism
and immune response as novel functions of matriptase. Although
matriptase has been shown to be present in immune cells [41] and
predicted to have some role in thymic homeostasis [42], its general
role as modulator of immune response is not well documented.
When more proteins involved in a common biological role harbor
an accessible cleavage site for the protease and share the
subcellular loci (and cell type and tissue distribution), then, it is
reasonable to assume a role for the protease in modulating such a
biological function.
Global prediction methods often over represent positive
candidates which fail the acid test of in vivo relevance. Subjective
validation of the kind described here may be used as an index of in
vivo relevance. While absolute correlation should await experi-
mental validation, we have devised means to restrict false positive
identifications. We believe that protein conformation is an
extremely critical parameter in this regard since this criterion
can be used to eliminate those proteins with inaccessible sites.
However a cleavable sequence may be exposed due to any of the
following modifications: (a) exosite binding [37,43], (b) post-
translational changes, (c) binding of allosteric effectors, (d)
unfolding by chaperones and (e) cleavage of a well accessible
alternate site by the same or a different protease. Alternatively, a
cleavable sequence may not be accessible because of protein-
protein interactions, steric hindrance due to the presence of a
disulfide bond or amino acid modification to name a few. A
combination of three parameters-sequence specificity, 3D struc-
tural information and experimental data would be extremely
valuable in more precise positive identification of an enzyme-
substrate pair. As more and more structures are determined by
structural consortiums worldwide, our ability to use this informa-
tion in the identification of novel substrates of proteases in general
will become more reliable and such information can be very vital
in eliminating experimental artifacts and to extrapolate in vitro
observations to normal physiological conditions.
IV Proteolytic network
Exposure of a previously inaccessible cleavage site by the action
of a protease raises interesting possibilities in functional regulation
and creating a reaction cascade. For example, an inaccessible site
in the protein could be exposed by the action of the same protease
or a different protease acting elsewhere which could impart new
function or help in terminating the function. We thought that such
enzyme substrate pairs could be linked via the criterion of relative
accessibility to build novel networks. Webs emanating from such a
network can connect the proteolytic world and other protein
regulatory networks like signal transduction, development, differ-
entiation and apoptosis.
In order to provide such novel insights we built a network of
proteases and substrates derived from PDB. Here we highlight a
small network formed by substrates of matriptase and furin which
share the same subcellular loci as the enzyme. We added two other
Figure 4. Assignment of functions to matriptase. Potential substrates of matriptase with rSASA $0.4 and with subcellular localization similar to
matriptase were grouped based on their function.
doi:10.1371/journal.pone.0005700.g004
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S9) and only those putative substrates common to furin and
matriptase were included (Figure 5A). Due to paucity of
structural information, the network is not well developed and
has limited nodes. One example is highlighted in Figure 5 (inset
B). Mast/stem cell growth factor receptor (2EC8) is best accessible
to matriptase (rSASA 0.74). Hepsin (a type II transmembrane
protease) and testisin (a GPI anchored serine protease) also have
cleavage sites on 2EC8 with rSASA values of 0.35 and 0.17
respectively. All three cleavage sites are in the extracellular
domain. Hypothetically, if all these enzymes were to cleave 2EC8,
then cleavage by testisin may require prior cleavage by matriptase.
We also built network from natural substrates used earlier to
determine rSASA values (Table S5). This network links metallo,
cysteine and serine protease families (Figure 5C). It is anticipated
that over the time when more structures are solved, these networks
will be fully appreciated and novel information would be derived.
Discussion
We believe that our method would be a very useful
complementary approach in the current day attempts at global
profiling of proteases and their substrates. The power of the
method lies in the use of short peptide motifs which on one hand
are big enough to provide specificity and on the other hand, small
enough to cover a broad spectrum of proteins and most
importantly the use of physiologically relevant filters namely,
accessibility in terms of folded structure of a protein and
subcellular localization.
We have chosen to use the artificial peptide substrates for each
protease to create a subset of query sequence to demonstrate how
the method in combination of physiologically relevant filters can
actually throw out the possible number of false positive hits. We
have illustrated this clearly using the example of matriptase, in
which case only ,2% of the original hits turn out to be potential
substrates. Again as illustrated before, additional sites within the
same protein for example in VGF1, VGF2 or uroplasminogen
activator are present within the cytoplasmic side of the membrane
and will not be cleaved by matriptase. Despite such filters, some of
the candidates may never be cleaved by the cognate protease.
Such false positive identifications however, are common to any
such global profiling attempts including experimental approaches.
In addition, there could be many potential substrates that are
not identified by our method. Our query data set represents 86%
of the total tripeptide substrates indicating potentially high sample
coverage. Nevertheless, alternative specificity determinants repre-
sented by amino acid occupancy for example at P2P1P19, is not
covered.
Proteases are also known to recognize additional binding sites
called the ‘exosite’ [37,43]. This additional specificity determinant
could play a very important role in discriminating between
different cleavage sites in the same protein, or between substrates
Figure 5. A proteolytic network based on rSASA values. A) Network was built using the program Cytoscape by linking substrates of furin,
hepsin, matriptase and testisin derived from the PDB database. Inset B shows one substrate which is differentially accessible to the three enzymes. C)
A network was similarly built using some of the proteases and their experimentally identified natural substrates.
doi:10.1371/journal.pone.0005700.g005
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could be an important determinant in cases where overlapping
specificities are possible among enzymes of the same catalytic type
[35]. Proteases also cleave substrates present in cellular compart-
ments other than their own based on the physiological demand or
during malignancy [44–46]. By demanding colocalization, our
method misses out on such substrates. In order to account for the
possibility that an authentic substrate could actually be in a
different compartment, we must know the pattern of distribution
of the protease in different compartments, in various tissues and
their regulated expression. Until substantial information becomes
available, a prerequisite in terms of subcellular co-localization (and
tissue distribution) and topology in the case of membrane proteins
ensures reliability of the prediction method. Sequence specificity
and surface accessibility are relatively broad criteria that can
include many such non-obvious or unconventional substrates.
We also imagine the use of an additional filter based on
structural criteria. Whether all the different target sequences
identified for a protease or the same sequence present on different
substrates would fit in the active site of the enzyme? While a
predetermined geometry could actually help in surface comple-
mentarity, a sequence of different topology could very well be
induced to fit the active site. It will be useful to come up with a
method that can predict whether a particular cleavable sequence
in the intact protein would fit in the enzyme active site. Those
sequences that cannot fit into the active site then can be excluded
as an unlikely substrate. Our attempt at modeling various peptide
sequences at the active site of matriptase and grading them based
on Glide score is a small step in this direction.
The accuracy of the prediction method largely depends on the
sequence information available to us. When stringent specificity
information becomes available for as many enzymes as possible,
accuracy of the prediction will also increase. We believe that
rigorous determination of position specific information within each
catalytic type, family and for each protease is necessary in this
regard. As an illustrative example, we looked at two structures one
of granzyme B and the other of matriptase, both of which belong
to the S1 family. Granzyme B has a clear preference for Asp at the
P1 position while matriptase shows a preference for Arg/Lys.
When the matriptase and granzyme B structures were superposed,
the overall fold of the two proteins was grossly similar. However,
the active site differences in the two structures are considerable
both in terms of the loop conformation of the residues (Gly216 to
Gly226) as well as the sequence of the active site residues. For
example, a crucial difference is in Asp189 being replaced by Thr
in granzyme B. This alone will cut down the interaction energy of
a matriptase substrate considerably within the granzyme B active
site. In addition, there are other differences between the two
structures - Gly226 in matriptase is replaced by an Arg residue - a
huge difference that will also contribute significantly to the steric
hindrance of the ligand in the active site. Also, Cys191 is replaced
by Phe, resulting in a breakage of a key disulfide bond which
probably is responsible for a lot of changes in the loop
conformations around the active site in granzyme B. These
observations, together with our docking results with matriptase
and the various short peptide sequences illustrate how structural
information at high resolution can help in understanding enzyme
specificity.
Although we have used our method to extract substrates of
serine proteases that belong to human, we have demonstrated the
suitability of our method to enzymes of three other catalytic types
as well. From the PDB, we have been able to identify natural
substrates harboring the octapeptide cleavage sequences reported
in MEROPS. Substrates of enzymes of all major catalytic type are
represented (Table S5) indicating that the method in principle is
applicable to endo proteases in general. In most instances, the
substrates for the human proteases would be the cognate human
proteins only, as in the case of the enzymes of the digestive system,
while in other instances this may include those of pathogenic
organisms [47]. It is quite likely that such sequence specific
information and accessibility in the context of the folded structure
of a protein could be important in determining cleavage of human
proteins by viral endo proteases under certain conditions [48–50].
Although the approach described here is useful for endo proteases
of any species or catalytic type, exceptions could be compartmen-
talized enzymes such as the ATP dependent proteases like
proteasomes which are presumed to unfold a protein prior to
degradation. Any 3D structural information is expected to be
destroyed well before the polypeptide reaches the catalytic
chamber and therefore surface accessibility may be irrelevant in
such cases. Sequence specific information may still be useful as
selective inhibitors have been designed for the different catalytic
sites within the proteolytic chamber [51]. Cleavage specificity may
also be dependent on many other factors.
Our method is probably not applicable to the following class of
enzymes: exopeptidase, amino and carboxy peptidases, oligopep-
tidases, tripeptidyl-peptidase and dipeptidases. Method is also not
applicable to enzymes involved in antigen processing and
presentation like those of endoplasmic reticulum associated amino
peptidase (ERAP) or thimmet oligo peptidase which are so far
known to cleave peptide products (which in general lack any
defined structure) generated upstream by the proteasome. We had
also made note of the following: our method is probably irrelevant
for many of the endo proteases present in the lysosomes. While the
structural information may not be as relevant as for say cytosolic
enzymes due to the acidic and denaturing environment milieu of
the lysosomes, the dependence on sequence specificity is unclear.
Even though we have used all the octapeptide cleavage sequences
from MEROPS, identification of substrates for lysosomal enzymes
like cathepsins may be treated as illustrative examples only.
In essence, we believe that we have come up with a simple
method to identify natural substrates of proteases using short
sequence motifs for initial screening (Figure 6). We identify
accessibility and subcellular localization as determinants of
physiological relevance. Using three dimensional structure of the
protein as a guide, we demonstrate novel network which can
integrate the world of proteolysis and other regulatory networks.
The basic principles suggested here can be extended to the study
of other endo proteases from human and other organisms as well.
We plan to deposit our results at our website, expand the approach
to other proteases and provide a server for search options.
Methods
Perl scripts were used for extraction (flat file/xml format) and
analysis of the data from databases. These programs were run on
Linux machine and/or Windows machine with ActivePerl
installed (version 5.8.8). The data and the results produced by
the scripts were stored in the CSV format files for statistical
analysis.
Analysis of cleavage site specificity
All the entries belonging to Homo sapiens from MEROPS
Release 7.70 (22
nd January 2008) were extracted and analyzed.
The cleavage site sequences reported for natural substrates of
various proteases in the MEROPS database were extracted and
propensities for each amino acid at every position (P49-P4) were
calculated.
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Cleavage sequences reported in protein substrates and small
peptide substrates reported for aspartate, cysteine, metallo and
serine proteases in the MEROPS database were extracted.
Validation of method
In order to validate our method, we considered two proteases;
furin and thrombin. In MEROPS, 27 and 98 known substrates are
reported for furin and thrombin respectively. We divided the
known substrates into two sets i.e. a training set and a test set with
16 and 55 octapeptides randomly chosen to represent the training
set for furin and thrombin respectively. These octapeptides were
then scanned against the test set which comprised of the uniprot
sequences of all serine protease substrates reported in MEROPS.
We then used a SQL query to extract P3P2P1P19 (tetrapeptide
query set) and P3P2P1 peptides (tripeptide query set) from the
octapeptides. These were again matched with the test set.
Extraction of potential substrates
The human proteome data (NCBI refseq down loaded on
Sep01 2008) and proteins with short stretches of disordered
regions from DisProt were downloaded to a local database. A
structural database of 772 proteins was constructed by placing a
query on the website www.rcsb.org (on 21
st May 2008) for single
chain proteins with .100 amino acids that belong to the
taxonomy class Homo sapiens. Structures with ,3A ˚ resolution
and those with .95% homology were not considered. Even
though single chain criterion was used, some of the proteins turned
out to be part of a protein complex. They were retained in the
analysis.
Surface accessibility calculations
SASA values were calculated for each potential substrate using
the POPS (Parameter OPtimized Surfaces) algorithm. Relative
SASA (rSASA) was calculated based on the formula given by [52].
Modeling of substrate binding to matriptase
The protein structure in the PDB entry 2GV6 was prepared
using the protein preparation wizard in the Schro ¨dinger software
graphical user interface Maestro (version 8.5). Preliminary models
of AEGRS with the terminal capping groups of ACE (acetamide -
N terminus) and NME (N-methyl - C terminus) were built with
random conformations using the ‘‘Builder’’ tool in Maestro (v8.5)
(MAESTRO: A Graphical User Interface for Schro ¨dinger Suite of
products (v8.5) developed and marketed by Schro ¨dinger LLC.,
120 W. 45th Street, New York NY 10036). After further
modifications detailed in the supplemental section, the tetrahedral
carbon was marked for covalent bonding to O
c atom of Ser195.
Subsequently, the conformations of the pentapeptide ligand and
covalently linked Serine residue were varied in the energy
optimization process as described in the supplemental section
(Text S1).
Compartmentalization of protease-substrate
The cellular localization for each protease and substrates
(proteins in the structural database) were gathered from GO
terms [40] at the PDB site and verified again at http://www.
uniprot.org/.
Construction of Biological Network
Biological network was constructed in Cytoscape [53] for
visualizing the interaction between a protease and its substrates.
Proteases and their substrates serve as the nodes. Our network is
based on the rSASA values. If the rSASA value is high, the
substrate has more chance of being cleaved by a protease and
hence such substrates are positioned close to the protease, whereas
those that have low rSASA value are positioned far away from the
protease.
All snapshots in this study were created using PYMOL
(DeLano, W.L., The PyMOL Molecular Graphics System (2002)
DeLano Scientific, San Carlos, CA USA).
Figure 6. Flow chart of the method. A schematic of our method for in silico screening of natural substrates of proteases is presented. If no
structure is available, colocalization can be used as the filter to identify putative substrates especially with the octapeptide as the QSS. Eventually
however experimental validation is inevitable.
doi:10.1371/journal.pone.0005700.g006
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